Duane Jon R 4

What Happened

• Duane Jon R, a director of Ironwood Pharmaceuticals, was granted 63,481 restricted shares on June 16, 2026. The Form 4 reports the acquisition as an award (code A) at $0.00 per share (total reported value $0), reflecting a restricted stock grant under the company's director compensation policy. This is a grant of equity compensation, not a purchase or sale.

Key Details

• Transaction date: 2026-06-16; Form 4 filed 2026-06-17.
• Price reported: $0.00 per share; Shares acquired: 63,481.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: The restricted stock was granted under the Second Amended and Restated Non-employee Director Compensation Policy (effective Jan 1, 2024) and "vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."
• Filing timeliness: Filed the day after the transaction (not indicated as late in the supplied data).

Context

• This is a routine director compensation grant (restricted stock) — recipients typically do not pay cash for these awards and vesting schedules can delay transferability or sale. Such grants are common and mainly reflect standard board pay rather than an immediate market signal.